{"cik":"0001868279","ticker":"AVBP","name":"ArriVent BioPharma, Inc.","sic_code":"2834","sic_description":"Pharmaceutical Preparations","exchange":"Nasdaq","state_of_incorporation":"DE","fiscal_year_end":"1231","first_filing_date":"2026-06-22","last_filing_date":"2026-06-22","url":"/sec/cik-0001868279","insider_summary":{"total_transactions":7,"unique_insiders":4,"latest_transaction":"2026-06-18"},"recent_filings":[{"accession_number":"0001213900-26-109019","form_type":"SCHEDULE 13G","form_type_family":"other","doc_date":"2026-10-13","title":"SCHEDULE 13G — ArriVent BioPharma, Inc. — 2026-10-13","url_slug":"/sec/cik-0001868279/schedule-13g/0001213900-26-109019","edgar_url":"https://www.sec.gov/Archives/edgar/data/1868279/0001213900-26-109019-index.html"},{"accession_number":"0001104659-26-115161","form_type":"8-K","form_type_family":"current","doc_date":"2026-10-13","title":"8-K — ArriVent BioPharma, Inc. — 2026-10-13","url_slug":"/sec/cik-0001868279/8-k/0001104659-26-115161","edgar_url":"https://www.sec.gov/Archives/edgar/data/1868279/0001104659-26-115161-index.html"},{"accession_number":"0001104659-26-113898","form_type":"8-K","form_type_family":"current","doc_date":"2026-10-06","title":"8-K — ArriVent BioPharma, Inc. — 2026-10-06","url_slug":"/sec/cik-0001868279/8-k/0001104659-26-113898","edgar_url":"https://www.sec.gov/Archives/edgar/data/1868279/0001104659-26-113898-index.html"},{"accession_number":"0001104659-26-094869","form_type":"8-K","form_type_family":"current","doc_date":"2026-08-12","title":"8-K — ArriVent BioPharma, Inc. — 2026-08-12","url_slug":"/sec/cik-0001868279/8-k/0001104659-26-094869","edgar_url":"https://www.sec.gov/Archives/edgar/data/1868279/0001104659-26-094869-index.html"},{"accession_number":"0001104659-26-094902","form_type":"10-Q","form_type_family":"quarterly","doc_date":"2026-08-12","title":"10-Q — ArriVent BioPharma, Inc. — 2026-08-12","url_slug":"/sec/cik-0001868279/10-q/0001104659-26-094902","edgar_url":"https://www.sec.gov/Archives/edgar/data/1868279/0001104659-26-094902-index.html"},{"accession_number":"0002012383-26-002185","form_type":"SCHEDULE 13G/A","form_type_family":"other","doc_date":"2026-07-27","title":"SCHEDULE 13G/A — ArriVent BioPharma, Inc. — 2026-07-27","url_slug":"/sec/cik-0001868279/schedule-13g-a/0002012383-26-002185","edgar_url":"https://www.sec.gov/Archives/edgar/data/1868279/0002012383-26-002185-index.html"},{"accession_number":"0001104659-26-076352","form_type":"8-K","form_type_family":"current","doc_date":"2026-06-22","title":"8-K — ArriVent BioPharma, Inc. — 2026-06-22","url_slug":"/sec/cik-0001868279/8-k/0001104659-26-076352","edgar_url":"https://www.sec.gov/Archives/edgar/data/1868279/0001104659-26-076352-index.html"}],"related_endpoints":{"profile":"/sec/AVBP/profile","timeline":"/sec/AVBP/timeline","peers":"/sec/AVBP/peers","insider_pulse":"/sec/AVBP/insider-pulse","insider_summary":"/sec/AVBP/insider-summary","insider_transactions":"/sec/AVBP/insider-transactions","form144":"/sec/AVBP/form144","holdings_as_filer":"/sec/AVBP/holdings","financial_facts":"/sec/AVBP/financial-facts","derivatives":"/sec/AVBP/derivatives","officers":"/sec/AVBP/officers","insider_network":"/sec/AVBP/insider-network","risk_flags":"/sec/AVBP/risk-flags","filings":"/sec/AVBP/filings","cross_topic_dossier":"/api/v1/dossier?ticker=AVBP"}}